Complexities of Secondary AML with Dr. Goldberg

Aaron Goldberg, MD, PhD

Join us as we speak with Dr. Aaron Goldberg from Memorial Sloan Kettering Cancer Center in New York City.  Dr. Goldberg discusses how secondary AML differs from AML and how treatment is determined. Secondary AML is a diagnosis of AML that has occurred after previous exposure to radiation or chemotherapy for another cancer or has evolved from a prior diagnosis of MDS, MPN or Aplastic Anemia.  In this episode, Dr. Goldberg points out the major difference between secondary AML and de novo AML and new, promising treatments.

Mentioned on this Episode:

Additional LLS Support Resources:

Support for this episode provided by Jazz Pharmaceuticals.

Leave a Comment

Your email address will not be published. Required fields are marked *